Fostroxacitabine bralpamide
N/A
Report date: 2026/05/23 20:00:57
NMEFirst In Class
Base Information
Drug NameFostroxacitabine bralpamide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A
Develop Information
Active CompaniesMedivir ABCha University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A